In another complementary study, the prognostic value of CDX2 was studied by Pilati et al. who concluded that CDX2 as an independent prognostic variable was related to the consensus molecular subtype classified based on the comprehensive gene expression levels across CRC stages. This evidence concerns the gene CDX2 and colorectal carcinoma.